午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海瀚香生物科技有限公司 Company Information
Company Name:    ShangHai Biochempartner Co.,Ltd
Tel:    177-54423994
Email:    2853530910@QQ.com
Nationality:    China
WebSite:    www.biochempartner.com
Product List:    7972
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Product List
I-BET567 1887237-54-8
Erlizumab 211323-03-4
Iratumumab 640735-09-7
Daunomycinone 21794-55-8
CCG-100602 1207113-88-9
Tivozanib hydrochloride hydrate 682745-41-1
CTB 451491-47-7
BMS-986176 1815613-42-3
PBD dimer 1222490-34-7
Farletuzuma 896723-44-7
TBI-166 1353734-12-9
UNC6934 2561494-77-5
HLY78 854847-61-3
6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid 851288-57-8
Sibrotuzumab 216669-97-5
Apixaban Impurity 38 1802522-36-6
Budesonide Impurity 7 3949-79-9
Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate 22965-12-4
Libivirumab 569658-79-3
Bapineuzumab 648895-38-9
Raxibacumab 565451-13-0
SIS3 1009104-85-1
FLT3-IN-3 2229050-90-0
Vapaliximab 336801-86-6
GSK3685032 2170137-61-6
Upadacitinib hemihydrate 2050057-56-0
Ecromeximab 292819-64-8
5,6-Dibromo-2,3-dimethylpyridine 117846-56-7
CR8, (R)-Isomer 294646-77-8
SJ-172550 431979-47-4
Ebastine Impurity F 1429071-63-5
(R)-Methyl 3-(5-bromopyridin-2-YL)-2-(boc-amino)propanoate 1391465-94-3
Reslizumab 241473-69-8
(S)-3-Phenylcyclohexanone 57344-86-2
Figitumumab 943453-46-1
elsilimomab 468715-71-1
ML 145 1164500-72-4
NE10790 152831-36-2
NVR-3-778 1445790-55-5
eIF4A3-IN-1 2095486-67-0
SHP389 2235394-90-6
RGD Trifluoroacetate 2378808-45-6
7-O-(Triethylsilyl) Baccatin III 115437-21-3
SP-8356 1454885-45-0
TSHR antagonist S37 1217616-61-9
Cixutumumab 947687-12-9
Rilotumumab 872514-65-3
Olokizumab 1007223-17-7
Pagibaximab 595566-61-3
Tefibazumab 521079-87-8
Teneliximab 395639-53-9
Phentolamine Analogue 1 47142-51-8
SSD114 554428-55-6
DGKα inhibitor CU-3 1815598-71-0
BVT948 39674-97-0
Yttrium (90Y) Tacatuzumab Tetraxetan 476413-07-7
Disitamab Vedotin 2136633-23-1
WAY-181187 hydrochloride 554403-08-6
Methyl (2S)-3-(5-bromopyridin-2-yl)-2-[(2-methylpropan-2- yl)oxycarbonylamino]-propanoate 656801-27-3
3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- 1821309-39-0
Anatumomab
Volociximab 558480-40-3
Besilesomab 537694-98-7
Pritumumab 499212-74-7
Ebastine Impurity G 1429071-65-7
(R)-3-Phenylcyclohexanone 34993-51-6
NL-1 188532-26-5
(R)-CR8 trihydrochloride 1786438-30-9
2-(Acetylamino)-5-chlorobenzenesulfonate Pyridine 54981-41-8
Ibalizumab 680188-33-4
Robatumumab 934235-44-6
Pactimibe (sulfate) 608510-47-0
YH53 1471484-62-4
4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid 2222116-02-9
1-Piperidineacetic acid, 4-[4-[(2,6-dioxo-3-piperidinyl)amino]phenyl]-, 1,1-dimethylethyl ester 2641512-32-3
Lipoxamycin hemisulfate 11075-87-9
Doxazosin Impurity C 617677-53-9
TY-52156 934369-14-9
Otelixizumab 881191-44-2
Elotuzumab 915296-00-3
Oxelumab 1186098-83-8
AMP-945 1393653-34-3
2-(4-Bromo-2,6-dimethylphenyl)acetonitrile 205035-09-2
Simufilam dihydrochloride 2480226-06-8
tert-butyl 4-(4-((2,6-dioxopiperidin-3-yl)amino)phenyl)piperidine-1-carboxylate 2259851-32-4
Edrecolomab 156586-89-9
Tert-butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate 1965304-61-3
Lemalesomab 250242-54-7
FIDAS-3 1266684-01-8
Exbivirumab 569658-80-6
Bivatuzumab
Sontuzumab 372075-37-1
Poloxin 321688-88-4
Buspirone EP Impurity C 257877-45-5
GSK 2033 1221277-90-2
EIT hydrobromide 1071-37-0
Tigatuzumab 918127-53-4
Panobacumab 885053-97-4
(2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine 1821248-00-3
1-Piperazinecarboxylic acid, 4-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]-, 1,1-dimethylethyl ester 2222120-27-4
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2007©  ChemicalBook. All rights reserved.